Distribution of fluconazole-resistant Candida bloodstream isolates among hospitals and inpatient services in Israel R. Ben-Ami, G. Rahav, H. Elinav,

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Candida species distribution and antifungal susceptibility testing according to European Committee on Antimicrobial Susceptibility Testing and new vs.

Laboratory diagnosis and biosafety issues of biological warfare agents

Vaccines for the elderly

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Gut bacterial microbiota and obesity

Incidence and outcome of Staphylococcus aureus endocarditis—a 10-year single-centre northern European experience H. Asgeirsson, A. Thalme, M. Kristjansson,

Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients

S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler

Differential association of fluconazole dose and dose/MIC ratio with mortality in patients with Candida albicans and non-albicans bloodstream infection

Herpes zoster in non-hospitalized children

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

A.K. Reddy, P. Garg, I. Kaur Clinical Microbiology and Infection

Candida glabrata fungaemia in intensive care units

In-vitro susceptibility and molecular characterisation of macrolide resistance mechanisms among Streptococcus pneumonia isolates in The Netherlands: the.

Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections D. Ben-David, R. Kordevani, N. Keller, I. Tal, A. Marzel, O. Gal-Mor, Y.

Quinolone resistance among Shigella spp

P. Nordmann, L. Poirel Clinical Microbiology and Infection

Distribution of fluconazole-resistant Candida bloodstream isolates among hospitals and inpatient services in Israel R. Ben-Ami, G. Rahav, H. Elinav,

Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008–2013 L.E.B. Nabarro, R.A. Lever, M. Armstrong,

Potential risk factors for infection with Candida spp

Nosocomial bloodstream infections in children: an 8-year experience at a tertiary-care hospital in Finland E. Sarvikivi, O. Lyytikäinen, M. Vaara, H.

Pan-drug-resistant Pseudomonas aeruginosa causing nosocomial infection at a university hospital in Taiwan P.R. Hsueh, S.P. Tseng, L.J. Teng, S.W. Ho

Clinical Microbiology and Infection

Identification of genetic markers of resistance to echinocandins, azoles and 5- fluorocytosine in Candida glabrata by next-generation sequencing: a feasibility.

Early initiation of appropriate treatment is associated with increased survival in cancer patients with Candida glabrata fungaemia: a potential benefit.

Vector control: a cornerstone in the malaria elimination campaign

Y. Maor, N. Belausov, D. Ben-David, G. Smollan, N. Keller, G. Rahav

Sofie Arens, Jan Verhaegen, Ludo Verbist

Candida species distribution and antifungal susceptibility testing according to European Committee on Antimicrobial Susceptibility Testing and new vs.

Training for the infectious diseases speciality in Norway

Bacteraemia caused by beta-haemolytic streptococci in North Queensland: changing trends over a 14-year period P. Harris, D.-A. Siew, M. Proud, P. Buettner,

Laboratory diagnosis and biosafety issues of biological warfare agents

Decreasing rates of resistance to penicillin, but not erythromycin, in Streptococcus pneumoniae after introduction of a policy to restrict antibiotic.

Metagenomics and probiotics

M. Aires-de-Sousa Clinical Microbiology and Infection

Laboratory diagnosis of Clostridium difficile disease

T.M. File Clinical Microbiology and Infection

A. S. Hadziyannis, I. Stephanou, K. Dimarogona, A. Pantazatou, D

Update on antifungal resistance in Aspergillus and Candida

Harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter isolates from food animals in the European Union S. Bronzwaer Clinical.

R. Luzzati, B. Allegranzi, L. Antozzi, L. Masala, E. Pegoraro, A

Eleven-year retrospective survey of candidaemia in a university hospital in southwestern Greece A. Spiliopoulou, S. Vamvakopoulou, C. Bartzavali, G.

Abstracts cont. Clinical Microbiology and Infection

Evaluation of eight commercial tests for Mycoplasma pneumoniae antibodies in the absence of acute infection R. Nir-Paz, A. Michael-Gayego, M. Ron, C.

Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida

Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,

Vaccines for the elderly

Clinical infection services—the Leiden experience

C. Gagliotti, L. Nobilio, M.L. Moro

L. R. Ásmundsdóttir, H. Erlendsdóttir, A. L. Gísladóttir, M

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

Changing pattern of candidaemia 2001–2006 and use of antifungal therapy at the University Hospital of Vienna, Austria E. Presterl, F. Daxböck, W. Graninger,

Brita Bruun, Henrik Westh, Jørgen Stenderup

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Outcome of prosthetic knee-associated infection: evaluation of 40 consecutive episodes at a single centre R.R. Laffer, P. Graber, P.E. Ochsner, W. Zimmerli

Modelling during an emergency: the 2009 H1N1 influenza pandemic

O. Megged, A.M. Yinnon, D. Raveh, B. Rudensky, Y. Schlesinger

Are we losing the fight against malaria one more time?

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain M. Puig-Asensio,

Comparative study of pediculicidal effect of medical plants

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Risk factors and clinical outcomes of candidaemia in patients treated for Clostridium difficile infection A. Russo, M. Falcone, M. Fantoni, R. Murri,

Presentation transcript:

Distribution of fluconazole-resistant Candida bloodstream isolates among hospitals and inpatient services in Israel R. Ben-Ami, G. Rahav, H. Elinav, I. Kassis, I. Shalit, T. Gottesman, O. Megged, M. Weinberger, P. Ciobotaro, P. Shitrit, G. Weber, A. Paz, D. Miron, I. Oren, J. Bishara, C. Block, N. Keller, D.P. Kontoyiannis, M. Giladi Clinical Microbiology and Infection Volume 19, Issue 8, Pages 752-756 (August 2013) DOI: 10.1111/1469-0691.12004 Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 Incidence rates of candidaemia by hospital size. Each marker represents a single medical centre. (a) Incidence rates of all candidaemia episodes; (b) incidence rates of fluconazole-resistant Candida bloodstream infection; (c) incidence rates of Candida krusei bloodstream infection; (d) incidence rates of fluconazole-resistant Candida glabrata bloodstream infection. Vertical dashed line marks the median hospital size of 600 beds. Clinical Microbiology and Infection 2013 19, 752-756DOI: (10.1111/1469-0691.12004) Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions